New Delhi: The Drugs Controller General of India (DCGI) has directed all states and Union Territories to immediately launch a nationwide inspection drive across pharmaceutical manufacturing units to ensure strict adherence to the revised Good Manufacturing Practices (GMP) norms under Schedule M.

The move comes amid rising concerns over drug quality and safety, following recent incidents such as the deaths of children in Madhya Pradesh allegedly linked to diethylene glycol (DEG)-contaminated cough syrups.

Schedule M, part of the Drugs and Cosmetics Act 1940 deals with 'Good Manufacturing Practices' to be followed by pharmaceutical manufacturing units in the country. Earlier, the Medical Dialogues Team had reported that the new guidelines issued on December 28 had stated the manufacture

See Full Page